EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The CEBPB–AP-1 (JunB/Fos) Axis Drives Neuroinflammation and Microglial Dysfunction Via TNF Signaling in Ischemic Stroke

Kun Liang, Shuangshuang Lu, Weihao Shi, Weijian Fan, Yijun Huang, Jianwei Chen, Lei Zhu

Inflammation · 2026

DOI: 10.1007/s10753-026-02525-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2026. Verfasst von Kun Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Neuroinflammatory Diseases, Microglia, CCAAT-Enhancer-Binding Protein-beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Training Program for Innovative Translation Capacity of Research-Oriented Physicians under the Second Round Three-Year Action Plan for Promoting Clinical S…, the 2025 Shanghai High-Quality Development Plan for Sci-Tech Industry-Innovative Drugs & Medical Devices Application Demonstration Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic stroke triggers a strong neuroinflammatory response, with microglia playing dual roles in both exacerbating tissue damage and promoting repair. The molecular mechanisms regulating microglial activation and polarization remain inadequately defined. In this study, we demonstrate that the transcription factor CEBPB is a key upstream regulator of the AP-1 (JunB-Fos) complex, driving pro-inflammatory transcriptional programs in microglia following transient focal cerebral ischemia (tFCI). Transcriptomic profiling of microglia from tFCI mice revealed significant gene expression changes, particularly enrichment in inflammatory, immune, and cytokine production pathways, and identified Cebpb, Junb, Fos, and Tnf as key hub genes. Mechanistically, CEBPB is upregulated in post-ischemic microglia and directly binds to the Fos promoter to activate AP-1, inducing downstream inflammatory mediators, including IL-1β and TNF-α. Inhibition of AP-1 with the selective inhibitor T-5224 shifted microglia from a pro-inflammatory to an anti-inflammatory phenotype in vitro, decreasing pro-inflammatory cytokine production and enhancing anti-inflammatory mediator release. In vivo, T-5224 treatment in tFCI mice suppressed neuroinflammation, reduced neuronal apoptosis in the striatum and cortex, promoted a restorative microglial phenotype, and improved long-term sensorimotor and cognitive function. These findings establish the CEBPB/AP-1 axis as a critical driver of neuroinflammation in ischemic stroke and highlight it as a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeNeuroinflammatory DiseasesMicrogliaCCAAT-Enhancer-Binding Protein-betaTranscription Factor AP-1AnimalsMiceMaleMice, Inbred C57BLGene Knockdown TechniquesCells, CulturedGene Expression ProfilingUp-RegulationNeuronsApoptosisParacrine CommunicationCognitionMorris Water Maze TestTranscription FactorsProto-Oncogene Proteins c-fos

Stichwörter der Autor:innen

AP-1CEBPBIschemic strokeMicrogliaNeuroinflammation

Substanzen

Cebpb protein, mouseCCAAT-Enhancer-Binding Protein-betaTranscription Factor AP-1JunB protein, mouseFos protein, mouseTranscription FactorsProto-Oncogene Proteins c-fos

Autor:innen und Institutionen

  • Department of Vascular Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Nursing, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, China. jianweichen1819@163.com.
  • Department of Vascular Surgery, Huashan Hospital, Fudan University, Shanghai, China. julian.lei.zhu@fudan.edu.cn.

Förderung

  • the Training Program for Innovative Translation Capacity of Research-Oriented Physicians under the Second Round Three-Year Action Plan for Promoting Clinical S…
  • the 2025 Shanghai High-Quality Development Plan for Sci-Tech Industry-Innovative Drugs & Medical Devices Application Demonstration Project

Zitieren

APA

Liang, K., Lu, S., Shi, W., Fan, W., Huang, Y., Chen, J., & Zhu, L. (2026). The CEBPB–AP-1 (JunB/Fos) Axis Drives Neuroinflammation and Microglial Dysfunction Via TNF Signaling in Ischemic Stroke. Inflammation. https://doi.org/10.1007/s10753-026-02525-3

Vancouver

Liang K, Lu S, Shi W, Fan W, Huang Y, Chen J, et al. The CEBPB–AP-1 (JunB/Fos) Axis Drives Neuroinflammation and Microglial Dysfunction Via TNF Signaling in Ischemic Stroke. Inflammation. 2026. doi:10.1007/s10753-026-02525-3

BibTeX
@article{Liang2026,
  author = {Liang, Kun and Lu, Shuangshuang and Shi, Weihao and Fan, Weijian and Huang, Yijun and Chen, Jianwei and Zhu, Lei},
  title = {The CEBPB–AP-1 (JunB/Fos) Axis Drives Neuroinflammation and Microglial Dysfunction Via TNF Signaling in Ischemic Stroke},
  journal = {Inflammation},
  year = {2026},
  doi = {10.1007/s10753-026-02525-3}
}
Kostenlos starten →